Inspired by previous studies64,65 and our data showing that acetate supplementation could rescue IFN-γ production and tumor killing ability of Hif1α− / − T cells in vitro, we asked if this could act as an effective strategy to bypass ICB resistance in Hif1α− / − tumor-bearing mice in vivo. This evidence concerns the gene HIF1A and neoplasm.